Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Stress-related hair loss was reversed with a special medication.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Upadacitinib improved multiple immune-related conditions in one patient.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Non-immune factors play a significant role in alopecia areata.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.